Koyfin Home > Directory > Health Care > Akebia Therapeutics > Total Debt / Capital

Akebia Therapeutics Total Debt / Capital Chart (AKBA)

Akebia Therapeutics annual/quarterly Total Debt / Capital from 2014 to 2020.
  • Akebia Therapeutics Total Debt / Capital for the quarter ending June 06, 2020 was $22m a 69.89% increase of 16m year over year
  • Akebia Therapeutics Total Debt / Capital for the last 12 months ending June 06, 2020 was $22m a 69.89% increase of 16m year over year
  • Akebia Therapeutics Annual Total Debt / Capital for 2019 was $22m a 89.30% increase of 19m from 2018
  • Akebia Therapeutics Annual Total Debt / Capital for 2018 was $2m
Other Ratios Metrics:
  • Akebia Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $95m a 0.76% increase of 1m year over year
  • Akebia Therapeutics Total Debt / Equity for the quarter ending December 12, 2018 was $2m a 99.31% increase of 2m year over year
View Chart On Koyfin

Quarterly AKBA Total Debt / Capital Data

06/2020$22m
03/2020$21m
12/2019$22m
09/2019$7m
06/2019$6m
03/2019$6m
12/2018$2m
09/2017$0m
06/2017$0m
03/2017$0m

Annual AKBA Total Debt / Capital Data

2019$22m
2018$2m